vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and WORKIVA INC (WK). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $247.3M, roughly 2.0× WORKIVA INC). WORKIVA INC runs the higher net margin — 7.7% vs 6.8%, a 0.9% gap on every dollar of revenue. On growth, WORKIVA INC posted the faster year-over-year revenue change (19.9% vs -1.7%). Over the past eight quarters, WORKIVA INC's revenue compounded faster (18.0% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Workiva, Inc. is a global software-as-a-service (SaaS) company. It provides a cloud-based connected and reporting compliance platform that enables the use of connected data and automation of reporting across finance, accounting, risk, and compliance.
MD vs WK — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $247.3M |
| Net Profit | $33.7M | $19.0M |
| Gross Margin | — | 80.4% |
| Operating Margin | 9.9% | 25.8% |
| Net Margin | 6.8% | 7.7% |
| Revenue YoY | -1.7% | 19.9% |
| Net Profit YoY | 10.5% | — |
| EPS (diluted) | $0.40 | $0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $247.3M | ||
| Q4 25 | $493.8M | $238.9M | ||
| Q3 25 | $492.9M | $224.2M | ||
| Q2 25 | $468.8M | $215.2M | ||
| Q1 25 | $458.4M | $206.3M | ||
| Q4 24 | $502.4M | $199.9M | ||
| Q3 24 | $511.2M | $185.6M | ||
| Q2 24 | $504.3M | $177.5M |
| Q1 26 | — | $19.0M | ||
| Q4 25 | $33.7M | $11.8M | ||
| Q3 25 | $71.7M | $2.8M | ||
| Q2 25 | $39.3M | $-19.4M | ||
| Q1 25 | $20.7M | $-21.4M | ||
| Q4 24 | $30.5M | $-8.8M | ||
| Q3 24 | $19.4M | $-17.0M | ||
| Q2 24 | $-153.0M | $-17.5M |
| Q1 26 | — | 80.4% | ||
| Q4 25 | — | 80.7% | ||
| Q3 25 | — | 79.3% | ||
| Q2 25 | — | 77.0% | ||
| Q1 25 | — | 76.6% | ||
| Q4 24 | — | 77.1% | ||
| Q3 24 | — | 76.5% | ||
| Q2 24 | — | 76.8% |
| Q1 26 | — | 25.8% | ||
| Q4 25 | 9.9% | 3.3% | ||
| Q3 25 | 13.8% | -1.5% | ||
| Q2 25 | 12.8% | -10.3% | ||
| Q1 25 | 7.0% | -12.0% | ||
| Q4 24 | 7.8% | -6.7% | ||
| Q3 24 | 6.6% | -11.7% | ||
| Q2 24 | -31.3% | -13.0% |
| Q1 26 | — | 7.7% | ||
| Q4 25 | 6.8% | 4.9% | ||
| Q3 25 | 14.5% | 1.2% | ||
| Q2 25 | 8.4% | -9.0% | ||
| Q1 25 | 4.5% | -10.4% | ||
| Q4 24 | 6.1% | -4.4% | ||
| Q3 24 | 3.8% | -9.2% | ||
| Q2 24 | -30.3% | -9.9% |
| Q1 26 | — | $0.33 | ||
| Q4 25 | $0.40 | $0.21 | ||
| Q3 25 | $0.84 | $0.05 | ||
| Q2 25 | $0.46 | $-0.35 | ||
| Q1 25 | $0.24 | $-0.38 | ||
| Q4 24 | $0.37 | $-0.15 | ||
| Q3 24 | $0.23 | $-0.31 | ||
| Q2 24 | $-1.84 | $-0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $334.3M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | — |
| Total Assets | $2.2B | $1.4B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $334.3M | ||
| Q4 25 | $375.2M | $338.8M | ||
| Q3 25 | $340.1M | $315.9M | ||
| Q2 25 | $224.7M | $284.3M | ||
| Q1 25 | $99.0M | $242.0M | ||
| Q4 24 | $229.9M | $301.8M | ||
| Q3 24 | $103.8M | $248.2M | ||
| Q2 24 | $19.4M | $267.9M |
| Q1 26 | — | — | ||
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
| Q1 26 | — | — | ||
| Q4 25 | $865.9M | $-5.4M | ||
| Q3 25 | $890.7M | $-36.9M | ||
| Q2 25 | $833.8M | $-66.5M | ||
| Q1 25 | $789.2M | $-75.7M | ||
| Q4 24 | $764.9M | $-41.7M | ||
| Q3 24 | $732.5M | $-50.8M | ||
| Q2 24 | $706.5M | $-77.7M |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.2B | $1.5B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.0B | $1.3B | ||
| Q4 24 | $2.2B | $1.4B | ||
| Q3 24 | $2.1B | $1.3B | ||
| Q2 24 | $2.0B | $1.2B |
| Q1 26 | — | — | ||
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | — |
| Free Cash FlowOCF − Capex | — | $25.7M |
| FCF MarginFCF / Revenue | — | 10.4% |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 3.39× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $171.9M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $114.1M | $51.0M | ||
| Q3 25 | $137.3M | $46.2M | ||
| Q2 25 | $137.2M | $50.3M | ||
| Q1 25 | $-117.5M | $-7.4M | ||
| Q4 24 | $133.0M | $44.0M | ||
| Q3 24 | $91.8M | $18.9M | ||
| Q2 24 | $107.0M | $-14.0K |
| Q1 26 | — | $25.7M | ||
| Q4 25 | — | $50.7M | ||
| Q3 25 | — | $46.1M | ||
| Q2 25 | — | $49.3M | ||
| Q1 25 | — | $-8.1M | ||
| Q4 24 | — | $43.2M | ||
| Q3 24 | — | $18.7M | ||
| Q2 24 | — | $-122.0K |
| Q1 26 | — | 10.4% | ||
| Q4 25 | — | 21.2% | ||
| Q3 25 | — | 20.5% | ||
| Q2 25 | — | 22.9% | ||
| Q1 25 | — | -3.9% | ||
| Q4 24 | — | 21.6% | ||
| Q3 24 | — | 10.1% | ||
| Q2 24 | — | -0.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.1% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.5% | ||
| Q1 25 | — | 0.4% | ||
| Q4 24 | — | 0.4% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.1% |
| Q1 26 | — | — | ||
| Q4 25 | 3.39× | 4.31× | ||
| Q3 25 | 1.91× | 16.57× | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | — | ||
| Q4 24 | 4.36× | — | ||
| Q3 24 | 4.72× | — | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
WK
| Subscription and support | $225.4M | 91% |
| Other | $22.0M | 9% |
